Liver fibrosis
http://www.100md.com
《神经病学神经外科学杂志》
Original citation: J. Clin. Invest. 115:209–218(2005). doi:10.1172/JCI200524282
Citation for this corrigendum: J. Clin. Invest. 115:1100 (2005). doi:10.1172/JCI200524282C1
PPARg agonists but not PPAR antagonists, as listed in Table 2, have shown inhibitory effects on HSCs and antifibrotic effects in animal models with liver fibrosis and patients with NASH.(Ramón Bataller and David )
Citation for this corrigendum: J. Clin. Invest. 115:1100 (2005). doi:10.1172/JCI200524282C1
PPARg agonists but not PPAR antagonists, as listed in Table 2, have shown inhibitory effects on HSCs and antifibrotic effects in animal models with liver fibrosis and patients with NASH.(Ramón Bataller and David )